Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01556256
Other study ID # ANUR1131
Secondary ID NCI-2012-00682CD
Status Completed
Phase N/A
First received
Last updated
Start date April 23, 2012
Est. completion date October 2, 2023

Study information

Verified date October 2023
Source Children's Oncology Group
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized trial studies how well music therapy and parents' education work in improving communication, emotional distress, and recovery in adolescents/young adult patients undergoing treatment for high-risk cancer and their parents. Making a music therapy video may improve communication, emotional distress, and recovery in younger patients undergoing treatment for cancer. It is not yet known whether music therapy and counseling for parents is more effective than information handouts for parents in improving communication and emotional distress in patients undergoing treatment for cancer.


Description:

PRIMARY OBJECTIVES: I. Compare the efficacy of a Therapeutic Music Video (TMV) intervention with a Therapeutic Music Video plus Parent (TMV+P) intervention on outcomes for adolescents/young adults (AYA) undergoing treatment for high-risk cancer. II. Compare the efficacy of a TMV intervention with a TMV+P intervention on outcomes for parents of AYA with high-risk cancer. III. Determine relationships of parent distress and parent perceived family environment with AYA outcomes using a mixed methods approach. (exploratory) OUTLINE: This is a multicenter study. Patients are stratified according to age in years (11-13 vs 14-17 vs 18-24). Parents are randomized to 1 of 2 intervention arms. ARM I (TMV, low-dose parent): AYA patients undergo 60-minute sessions, delivered in a private setting during outpatient clinic visits or hospitalizations, within a 6-8 weeks period with board-certified music therapists. The music therapists help patients in brainstorming and lyric writing, singing and creatively exploring how AYA lyrics and structure of the selected music fit together, recording their song with a digital accompaniment track, completing video layout worksheets (determining the contents of the video), taking and gathering photos or making drawings for the video, and viewing clip art and pictures on a computer. The music therapist then digitally formats, compiles, and transfers the AYA-developed music video to a DVD. When completed, the therapist shares the video with the AYA and offers the option of having a video "premiere." AYAs who choose a premiere select a date and time for the viewing and identify individuals they wish to attend (family, friends, healthcare professionals). After the viewing, AYAs receive a copy of their DVD to keep. Parents' presence and involvement during all sessions are directed by the AYAs. Parents receive 2 sessions over 15-60 minutes with a trained study team. During the first session, parents receive handouts of helpful website resources that have specific information to help parents support their AYAs. Team members also assure that parents know how to assess the sites. During the second session, parents receive audio-recorded, telephone-based contact by a trained nurse who asks them questions focusing on the content available on the provided website. The trained nurse also answers any questions parents may have. ARM II (AYA TMV +P): AYA patients receive intervention as patients in arm I. Parents receive 3 tailored 60-minute sessions with a trained nurse intervener. Sessions are recorded to make sure study nurse delivers the sessions according to the study protocol. Study nurse provides support information to parents using the Robb's Contextual Support Model, including Managing the Chaos: Self Care as the First Step to Caring for Your AYA, Relationship Support: How to Listen to and Encourage Your AYA to Talk; and Strategies for AYA Autonomy Support: Understanding AYA's Ways of Coping. Session 3 content is also based on the Resilience in Illness model. Sessions are also tailored to parents' needs, skills practice and/or role playing, and reflection on and reinforcement of learning. Parents receive written materials on tips and prescribed skills practice plans. AYA and parents complete questionnaires including Illness-Related Distress, Defensive Coping, Spiritual Perspective, Social Integration, Family Environment questionnaires, Hope-Derived Meaning, Self-Transcendence, Positive Coping, Resilience, Parent Distress, and Quality of Life at baseline, at 2 weeks after final session, and then at 90 days after final intervention session. Medical background, intensity of treatment rating scale, and family demographics are also collected.


Recruitment information / eligibility

Status Completed
Enrollment 124
Est. completion date October 2, 2023
Est. primary completion date August 31, 2016
Accepts healthy volunteers No
Gender All
Age group 11 Years to 24 Years
Eligibility Inclusion Criteria: - AYA has initial or relapsed cancer diagnosis and is actively on treatment and will continue to be on treatment long enough to complete the intervention and evaluation (4 to 6 weeks) - AYA meets at least 1 of 3 criteria indicating potentially high palliative care or end-of-life needs: - Any high-risk cancer (i.e., metastatic or stage IV) - Receiving moderate- to high-intensity chemotherapy during 3-5 consecutive days in an in- or out-patient setting - A diagnosis with an estimated 5-year event-free survival of < 50% - AYA is able to participate in sessions as evaluated by the Karnofsky/Lansky score of 50% or greater - One consistent parent is willing and available to participate in all parent and evaluation sessions - AYA is not married and has no children - AYA and parent are able to read, understand, and speak English Exclusion Criteria: - Cancers not usually occurring in childhood/adolescent or young adult populations, such as lung or prostate cancer - Cognitive impairments that would make it difficult for AYA/parents to participate in the intervention or complete questionnaires (determination in consultation with attending physician, oncologist, and, for adolescents below age 18, the parents)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Caregiver-Related Intervention or Procedure
Undergo TMV+P
Procedure:
Music Therapy
Undergo TMV
Music Therapy
Undergo TMV+P
Other:
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies

Locations

Country Name City State
United States Children's Healthcare of Atlanta - Egleston Atlanta Georgia
United States Children's Healthcare of Atlanta - Scottish Rite Atlanta Georgia
United States Cincinnati Children's Hospital Medical Center Cincinnati Ohio
United States Cook Children's Medical Center Fort Worth Texas
United States Riley Hospital for Children Indianapolis Indiana
United States Children's Mercy Hospitals and Clinics Kansas City Missouri
United States Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis Minnesota
United States University of Texas Health Science Center at San Antonio San Antonio Texas

Sponsors (2)

Lead Sponsor Collaborator
Children's Oncology Group National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary AYA illness-related distress measured by the Mishel Uncertainty in Illness Scale and the McCorkle Symptom Distress scale The MPLUS software will be used to perform latent variable analysis of covariance (ANCOVA) to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary AYA defensive coping measured by the Jalowiec Coping Scale-Revised The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary AYA spiritual perspective measured by the Reed Spiritual Perspective Scale The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary AYA social integration measured by the Perceived Social Support-Family scale, the Perceived Social Support-Friends scale, and the Perceived Social Support-Health Care Providers The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary AYA family environment measured by the Family Adaptability and Cohesion Scale II The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary AYA family environment measured by the Parent-Adolescent Communication scale The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary AYA family environment measured by the Family Strengths Scale The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary AYA positive coping measured by the Jalowiec Coping Scale-Revised The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary AYA hope-derived meaning measured by the Herth Hope Index The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary AYA self-transcendence measured by the Reed Self-Transcendence scale The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary AYA resilience measured by the Nowotny Confidence subscale, the Haase Resilience in Illness Scale, and the Index of Well-Being The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary Parental distress measured by the Perceived Stress Scale, the Profile of Mood States-Short Form, and the Spielberger's State-Trait Anxiety Inventory-State Component The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary Parent family environment measured by the Family Adaptability and Cohesion Scale The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary Parent family environment measured by the Parent-Adolescent Communication scale The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary Parent family environment measured by the Family Strengths Scale The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary Parent family environment measured by the Perceived Social Support-Health Care Providers The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
Primary Parent quality of life measured by the Index of Well-being The MPLUS software will be used to perform latent variable ANCOVA to account for measurement error and to reduce the number of comparisons. Up to 90 days
See also
  Status Clinical Trial Phase
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Active, not recruiting NCT02243592 - Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment
Completed NCT03445572 - Meditative Slow Breathing or Isha Kriya Meditation in Improving Cancer-Related Symptoms in Hospitalized Participants With Cancer N/A
Active, not recruiting NCT02860039 - High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant Phase 2
Completed NCT01946217 - Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials N/A
Completed NCT01635413 - Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial) N/A
Completed NCT00026169 - Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure Phase 1
Recruiting NCT04534075 - Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial Phase 3
Active, not recruiting NCT01806129 - Reproductive Health Program in Patients With Cancer N/A
Recruiting NCT03915717 - Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring
Recruiting NCT02280161 - Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
Recruiting NCT05520281 - Short-term Psychodynamic Psychotherapy in Serious Physical Illness N/A
Terminated NCT00532064 - Cardiac Biomarkers in Early Detection of Cardiotoxicity in Patients Receiving Sunitinib or Sorafenib Chemotherapy
Completed NCT04990882 - FAPI PET/CT Prospective Interobserver Agreement
Completed NCT01896778 - Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer N/A
Recruiting NCT05770102 - DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition Phase 2/Phase 3
Recruiting NCT06090266 - A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Recruiting NCT05886764 - Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials N/A
Completed NCT01506440 - Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy
Completed NCT01432431 - Spiritual Care in Improving Quality of Life of Patients, Caregivers, and Hospital Staff N/A